Trustees Of Princeton University Adverum Biotechnologies, Inc. Transaction History

Trustees Of Princeton University

  • $7.77 Million
  • Q4 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$1.74 - $2.4 $129,682 - $178,872
-74,530 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$9.84 - $14.26 $733,375 - $1.06 Million
74,530 New
74,530 $808,000

Others Institutions Holding ADVM

# of Institutions
3
Shares Held
524K
Call Options Held
0
Put Options Held
0
View Full List

About Adverum Biotechnologies, Inc.

ADVM Quotes by TradingView
  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $611M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Trustees Of Princeton University Portfolio

Follow Trustees Of Princeton University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustees Of Princeton University, based on Form 13F filings with the SEC.

News

Stay updated on Trustees Of Princeton University with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email